Publications by authors named "Midori Shida"

Claim this Profile
C
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.
Kohei Tajima, Masahiro Hosonuma, Eiji Funayama, Junya Isobe, Yuta Baba, Midori Shida

Int J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
Yoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Eiji Funayama, Midori Shida

Cancer Immunol Immunother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice.
Yuki Maruyama, Masahiro Hosonuma, Hitoshi Toyoda, Eiji Funayama, Akiko Sasaki, Midori Shida

Eur J Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.
Yuya Hirasawa, Junya Isobe, Masahiro Hosonuma, Toshiaki Tsurui, Yuta Baba, Midori Shida

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8 T cells as a predictor of clinical benefit.
Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, Yuuki Maruyama, Yasunobu Amari, Midori Shida

Discov Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.
Eiji Funayama, Masahiro Hosonuma, Kohei Tajima, Junya Isobe, Yuta Baba, Midori Shida

Biomed Pharmacother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2D T cells.
Hitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Yoichiro Narikawa, Midori Shida

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, Sei Kobayashi, Akiko Sasaki, Midori Shida

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
Masahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu, Masakazu Murayama, Yoichiro Narikawa, Midori Shida

Cancer Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
Koji Otsuka, Junya Isobe, Yoshiyuki Asai, Tomohisa Nakano, Kouya Hattori, Midori Shida

Cancer Immunol Immunother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and predict immune-related adverse events and efficacy of immune checkpoint inhibitor.
Kazuyuki Hamada, Junya Isobe, Kouya Hattori, Masahiro Hosonuma, Yuta Baba, Midori Shida

Front Immunol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report.
Kazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, Yuya Hirasawa, Hirotsugu Ariizumi, Midori Shida, Hiroo Ishida

Medicine (Baltimore)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy.
Kazuyuki Hamada, Kiyoshi Yoshimura, Yuya Hirasawa, Masahiro Hosonuma, Masakazu Murayama, Midori Shida

Anticancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer.
Yutaro Kubota, Kiyoshi Yoshimura, Kazuyuki Hamada, Yuya Hirasawa, Midori Shida, Hiroo Ishida

In Vivo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.
Yuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, Yutaro Kubota, Hiroo Ishida, Midori Shida

Medicine (Baltimore)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high number of PD-L1 CD14 monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.
Kiyohiro Ando, Kazuyuki Hamada, Midori Shida, Ryotaro Ohkuma, Yutaro Kubota

Cancer Immunol Immunother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, Daisuke Komura, Yutaro Kubota, Midori Shida

Int J Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, Daisuke Komura, Yutaro Kubota, Midori Shida

Oncol Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, Daisuke Komura, Hidenobu Ishizaki, Hiroo Ishida, Midori Shida

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors.
Kiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe, Ryotaro Ohkuma, Midori Shida

Anticancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis